Vertex Pharmaceuticals (VRTX) stock has performed strongly since the turn of the year, gaining 14.6% and vastly outperforming the healthcare ...

Get prepared with the key expectations. Vertex Pharmaceuticals (NASDAQ: VRTX) has long been known as the company to turn to for life-saving cystic fibrosis (CF) drugs, and this platform has helped ...

Clinical trial disappointments and technical sell signals pressure VRTX, down 15% over six months. Brand New Membership Level: Benzinga Trade Alerts This occurs when the 50-day moving average ...

Vertex Pharmaceuticals (VRTX) has been one of the most searched ... Vertex is rated Zacks Rank #3 (Hold). The chart below shows the evolution of the company's forward 12-month consensus EPS ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Below is a chart showing VRTX's trailing twelve month trading history, with the $450.00 strike highlighted in red: Considering the fact that the $450.00 strike represents an approximate 3% premium ...

Below is a chart showing VRTX's trailing twelve month trading history, with the $470 strike highlighted in orange: Akamai Technologies Inc (Symbol: AKAM) options are showing a volume of 14,642 ...

In the latest market close, Vertex Pharmaceuticals (VRTX) reached $409.56, with a -0.62% movement compared to the previous day. This change was narrower than the S&P 500's 1.54% loss on the day.

MaxCyte: Building the Future of Cell and Gene Therapy Innovation MaxCyte Inc. (NASDAQ:MXCT) is a global developer of next-generation cell therapies. They provide crucial technology for cell and ...

U.S.-based Vertex Pharmaceuticals (VRTX) has secured approval from the FDA (Food and Drug Administration) for its ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...